Sequence variations and plasma VWF laboratory parameters in type 2A VWD patients
Patient no. . | Nucleotide . | Amino acid . | Exon . | Domain . | VWF:Ag, IU/dL . | VWF:RCo, IU/dL . | VWF:RCo/VWF:Ag . | VWFpp, U/dL . | VWFpp/VWF:Ag . | FVIII:C, IU/dL . | ABO . | Multimer . |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1† | 2220G > A | M740I* | 17 | D2 | 185 | 25 | 0.1 | 89 | 0.5 | 156 | A | Abnormal |
3569G > C | C1190S | 27 | D3 | |||||||||
2† | 2220G > A | M740I* | 17 | D2 | 152 | 34 | 0.2 | 71 | 0.5 | 146 | A | Abnormal |
3569G > C | C1190S | 27 | D3 | |||||||||
4138A > G | I1380V | 28 | A1 | |||||||||
3† | 4138A > G | I1380V | 28 | A1 | 144 | 130 | 0.9 | N/A | N/A | 226 | AB | Normal |
4 | 3295T > C | C1099P | 25 | D3 | 139 | 44 | 0.3 | 80 | 0.6 | 75 | A | Abnormal |
3296G > C | ||||||||||||
5 | 3814T > C | C1272R* | 28 | A1 | 42 | < 10 | < 0.2 | N/A | N/A | 19 | N/A | N/A |
6 | 3815G > C | C1272S* | 28 | A1 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
7 | 3815G > A | C1272Y | 28 | A1 | 18 | < 10 | < 0.6 | 103 | 5.7 | 33 | N/A | Abnormal |
8 | 4508T > G | L1503R* | 28 | A2 | 22 | < 10 | < 0.5 | 52 | 2.4 | N/A | A | Abnormal |
9 | 4517C > T | S1506L* | 28 | A2 | 19 | < 10 | < 0.5 | 57 | 3.0 | 27 | A | Abnormal |
10 | 4703T > A | I1568N | 28 | A2 | 36 | 5 | 0.1 | 59 | 1.6 | 37 | B | Abnormal |
11 | 4735G > A | G1579R | 28 | A2 | 44 | 9 | 0.2 | 134 | 3.0 | 32 | N/A | Abnormal |
12 | 4820T > A | V1607D* | 28 | A2 | 19 | 6 | 0.3 | 30 | 1.6 | 54 | N/A | Abnormal |
13 | 4892G > A | G1631D* | 28 | A2 | 22 | < 10 | < 0.5 | 60 | 2.7 | 31 | A | Abnormal |
Patient no. . | Nucleotide . | Amino acid . | Exon . | Domain . | VWF:Ag, IU/dL . | VWF:RCo, IU/dL . | VWF:RCo/VWF:Ag . | VWFpp, U/dL . | VWFpp/VWF:Ag . | FVIII:C, IU/dL . | ABO . | Multimer . |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1† | 2220G > A | M740I* | 17 | D2 | 185 | 25 | 0.1 | 89 | 0.5 | 156 | A | Abnormal |
3569G > C | C1190S | 27 | D3 | |||||||||
2† | 2220G > A | M740I* | 17 | D2 | 152 | 34 | 0.2 | 71 | 0.5 | 146 | A | Abnormal |
3569G > C | C1190S | 27 | D3 | |||||||||
4138A > G | I1380V | 28 | A1 | |||||||||
3† | 4138A > G | I1380V | 28 | A1 | 144 | 130 | 0.9 | N/A | N/A | 226 | AB | Normal |
4 | 3295T > C | C1099P | 25 | D3 | 139 | 44 | 0.3 | 80 | 0.6 | 75 | A | Abnormal |
3296G > C | ||||||||||||
5 | 3814T > C | C1272R* | 28 | A1 | 42 | < 10 | < 0.2 | N/A | N/A | 19 | N/A | N/A |
6 | 3815G > C | C1272S* | 28 | A1 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
7 | 3815G > A | C1272Y | 28 | A1 | 18 | < 10 | < 0.6 | 103 | 5.7 | 33 | N/A | Abnormal |
8 | 4508T > G | L1503R* | 28 | A2 | 22 | < 10 | < 0.5 | 52 | 2.4 | N/A | A | Abnormal |
9 | 4517C > T | S1506L* | 28 | A2 | 19 | < 10 | < 0.5 | 57 | 3.0 | 27 | A | Abnormal |
10 | 4703T > A | I1568N | 28 | A2 | 36 | 5 | 0.1 | 59 | 1.6 | 37 | B | Abnormal |
11 | 4735G > A | G1579R | 28 | A2 | 44 | 9 | 0.2 | 134 | 3.0 | 32 | N/A | Abnormal |
12 | 4820T > A | V1607D* | 28 | A2 | 19 | 6 | 0.3 | 30 | 1.6 | 54 | N/A | Abnormal |
13 | 4892G > A | G1631D* | 28 | A2 | 22 | < 10 | < 0.5 | 60 | 2.7 | 31 | A | Abnormal |
Reference ranges are: VWF:Ag, 50-240 IU/dL; VWF:RCo, 54-279 IU/dL; VWFpp, 55-141 U/dL; and FVIII:C, 60-195 IU/dL.
N/A indicates not applicable.
Family members. Patients 1 and 2 are affected; patient 3 is unaffected.